Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1498382/000121390019019207/f8k092619_delmarpharma.htm
August 2020
June 2020
June 2020
June 2020
May 2020
May 2020
April 2020
March 2020
February 2020
January 2020
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1498382/000121390019019207/f8k092619_delmarpharma.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Delmar Pharmaceuticals, Inc..
Delmar Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Ticker: DMPIEvents:
CIK: 1498382
Form Type: 8-K Corporate News
Accession Number: 0001213900-19-019207
Submitted to the SEC: Fri Sep 27 2019 5:08:38 PM EST
Accepted by the SEC: Fri Sep 27 2019
Period: Thursday, September 26, 2019
Industry: Pharmaceutical Preparations